174 related articles for article (PubMed ID: 36301719)
1. Determining the temporal, dose, and composition effects of nutritional substrates in an in vitro model of intrahepatocellular triglyceride accumulation.
Nagarajan SR; Cross E; Johnson E; Sanna F; Daniels LJ; Ray DW; Hodson L
Physiol Rep; 2022 Oct; 10(20):e15463. PubMed ID: 36301719
[TBL] [Abstract][Full Text] [Related]
2. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis.
Gunn PJ; Pramfalk C; Millar V; Cornfield T; Hutchinson M; Johnson EM; Nagarajan SR; Troncoso-Rey P; Mithen RF; Pinnick KE; Traka MH; Green CJ; Hodson L
Physiol Rep; 2020 Jul; 8(13):e14482. PubMed ID: 32643289
[TBL] [Abstract][Full Text] [Related]
3. Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line.
Green CJ; Johnson D; Amin HD; Sivathondan P; Silva MA; Wang LM; Stevanato L; McNeil CA; Miljan EA; Sinden JD; Morten KJ; Hodson L
Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E511-22. PubMed ID: 26126685
[TBL] [Abstract][Full Text] [Related]
4. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
[TBL] [Abstract][Full Text] [Related]
5. FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity.
Wu K; Zhao T; Hogstrand C; Xu YC; Ling SC; Chen GH; Luo Z
Cell Commun Signal; 2020 Mar; 18(1):47. PubMed ID: 32192487
[TBL] [Abstract][Full Text] [Related]
6. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
[TBL] [Abstract][Full Text] [Related]
7. Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates.
Kamath S; Chavez AO; Gastaldelli A; Casiraghi F; Halff GA; Abrahamian GA; Davalli AM; Bastarrachea RA; Comuzzie AG; Guardado-Mendoza R; Jimenez-Ceja LM; Mattern V; Paez AM; Ricotti A; Tejero ME; Higgins PB; Rodriguez-Sanchez IP; Tripathy D; DeFronzo RA; Dick EJ; Cline GW; Folli F
PLoS One; 2011; 6(11):e27617. PubMed ID: 22125617
[TBL] [Abstract][Full Text] [Related]
8. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
10. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
11. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
12. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32188593
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
Li T; Huang X; Yue Z; Meng L; Hu Y
Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Effects of Monounsaturated Fatty Acids and Polyunsaturated Fatty Acids on Liver Lipid Disorders in Obese Mice.
Liu W; Zhu M; Gong M; Zheng W; Zeng X; Zheng Q; Li X; Fu F; Chen Y; Cheng J; Rao Z; Lu Y; Chen Y
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513618
[TBL] [Abstract][Full Text] [Related]
15. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
[TBL] [Abstract][Full Text] [Related]
16. Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.
Amorim R; Simões ICM; Veloso C; Carvalho A; Simões RF; Pereira FB; Thiel T; Normann A; Morais C; Jurado AS; Wieckowski MR; Teixeira J; Oliveira PJ
Nutrients; 2021 May; 13(5):. PubMed ID: 34069635
[TBL] [Abstract][Full Text] [Related]
17. Loss and gain of function of Grp75 or mitofusin 2 distinctly alter cholesterol metabolism, but all promote triglyceride accumulation in hepatocytes.
Bassot A; Prip-Buus C; Alves A; Berdeaux O; Perrier J; Lenoir V; Ji-Cao J; Berger MA; Loizon E; Cabaret S; Panthu B; Rieusset J; Morio B
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Dec; 1866(12):159030. PubMed ID: 34419589
[TBL] [Abstract][Full Text] [Related]
18. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations.
Green CJ; Pramfalk C; Morten KJ; Hodson L
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E1-20. PubMed ID: 25352434
[TBL] [Abstract][Full Text] [Related]
19. Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis.
Vergani L
Curr Med Chem; 2019; 26(19):3439-3456. PubMed ID: 28521680
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride Metabolism in the Liver.
Alves-Bezerra M; Cohen DE
Compr Physiol; 2017 Dec; 8(1):1-8. PubMed ID: 29357123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
